205 related articles for article (PubMed ID: 2974739)
1. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.
Cook NS; Weir SW; Danzeisen MC
Br J Pharmacol; 1988 Nov; 95(3):741-52. PubMed ID: 2974739
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
3. Cromakalim inhibits contractions of the rat isolated mesenteric bed induced by noradrenaline but not caffeine in Ca(2+)-free medium: evidence for interference with receptor-mediated Ca2+ mobilization.
Quast U; Baumlin Y
Eur J Pharmacol; 1991 Aug; 200(2-3):239-49. PubMed ID: 1782988
[TBL] [Abstract][Full Text] [Related]
4. Capacitative Ca2+ entry associated with alpha1-adrenoceptors in rat aorta.
Noguera MA; Ivorra MD; Chuliá S; D'Ocon P
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):83-9. PubMed ID: 9228194
[TBL] [Abstract][Full Text] [Related]
5. Effect of cromakalim on contractions in rabbit isolated renal artery in the presence and absence of extracellular Ca2+.
Wilson C; Cooper SM
Br J Pharmacol; 1989 Dec; 98(4):1303-11. PubMed ID: 2575415
[TBL] [Abstract][Full Text] [Related]
6. Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta.
Bray KM; Weston AH; Duty S; Newgreen DT; Longmore J; Edwards G; Brown TJ
Br J Pharmacol; 1991 Feb; 102(2):337-44. PubMed ID: 2015418
[TBL] [Abstract][Full Text] [Related]
7. Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.
Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
Eur J Pharmacol; 1988 Oct; 155(3):229-37. PubMed ID: 3234486
[TBL] [Abstract][Full Text] [Related]
8. Effects of K+ channel blockers on the relaxant action of dihydralazine, cromakalim and nitroprusside in isolated rabbit femoral arteries.
Thirstrup S; Nielsen-Kudsk JE
Eur J Pharmacol; 1992 May; 215(2-3):177-83. PubMed ID: 1396985
[TBL] [Abstract][Full Text] [Related]
9. Effects of glibenclamide on cytosolic calcium concentrations and on contraction of the rabbit aorta.
Yoshitake K; Hirano K; Kanaide H
Br J Pharmacol; 1991 Jan; 102(1):113-8. PubMed ID: 1904292
[TBL] [Abstract][Full Text] [Related]
10. Effect of cromakalim on KCl-, noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery.
Savineau JP; Marthan R
Pulm Pharmacol; 1993 Mar; 6(1):41-8. PubMed ID: 8477154
[TBL] [Abstract][Full Text] [Related]
11. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
[TBL] [Abstract][Full Text] [Related]
12. Effects of the K+ channel blocker tedisamil on 86Rb efflux induced by cromakalim, high potassium and noradrenaline, and on mechanical tension in rabbit isolated vascular smooth muscle.
Kreye VA; Pfründer D; Theiss U
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):238-43. PubMed ID: 1570026
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution.
Duty S; Weston AH
Br J Pharmacol; 1992 Dec; 107(4):1198-204. PubMed ID: 1467840
[TBL] [Abstract][Full Text] [Related]
14. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies on the interactions of beta2-adrenoceptor agonists, methylxanthines, Ca2+-channel blockers, K+-channel openers and other airway smooth muscle relaxants in isolated guinea-pig trachea.
Thirstrup S; Nielsen-Kudsk F; Dahl R
Eur J Pharmacol; 1997 May; 326(2-3):191-200. PubMed ID: 9196272
[TBL] [Abstract][Full Text] [Related]
16. Functional study on the effects of nifedipine, cromakalim, and the absence of extracellular Ca2+ on alpha 1-adrenoceptor-mediated excitation-contraction coupling in isolated rat portal vein: comparison with depolarization-mediated excitation-contraction coupling.
Schwietert R; Wilhelm D; Wilffert B; van Zwieten PA
J Cardiovasc Pharmacol; 1993 May; 21(5):739-48. PubMed ID: 7685443
[TBL] [Abstract][Full Text] [Related]
17. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.
Kawahara J; Izumi H; Okada Y; Izawa T
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):460-5. PubMed ID: 8897449
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
19. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
Quast U; Villhauer EB
Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
[TBL] [Abstract][Full Text] [Related]
20. Cromakalim inhibits multiple mechanisms of smooth muscle activation with similar stereoselectivity.
Kühberger E; Kukovetz WR; Groschner K
J Cardiovasc Pharmacol; 1993 Jun; 21(6):947-54. PubMed ID: 7687721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
